NASDAQ
Genetic Technologies Limited (GENE) has a current ratio of 0.88x as of Monday, May 25, 2026. This represents a 89.55% decrease compared to its 12-month average of 8.43x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.